Ed Ridley-Day
Stock Analyst at Rothschild & Co
(n/a)
# 4,871
Out of 5,090 analysts
8
Total ratings
n/a
Success rate
-27.32%
Average return
Main Sectors:
Stocks Rated by Ed Ridley-Day
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Downgrades: Neutral | $245 → $220 | $226.25 | -2.76% | 1 | Oct 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $130 | $94.28 | +37.89% | 1 | Sep 18, 2025 | |
| SYK Stryker | Initiates: Neutral | $420 | $364.02 | +15.38% | 1 | Sep 18, 2025 | |
| QGEN Qiagen | Downgrades: Neutral | n/a | $47.01 | - | 1 | Apr 4, 2025 | |
| LNTH Lantheus Holdings | Initiates: Buy | $175 | $63.30 | +176.46% | 1 | Sep 3, 2024 | |
| ISRG Intuitive Surgical | Upgrades: Buy | $380 → $510 | $575.34 | -11.36% | 2 | Aug 2, 2024 | |
| GEHC GE HealthCare Technologies | Initiates: Buy | n/a | $85.46 | - | 1 | Jan 19, 2023 |
Danaher
Oct 8, 2025
Downgrades: Neutral
Price Target: $245 → $220
Current: $226.25
Upside: -2.76%
Zimmer Biomet Holdings
Sep 18, 2025
Initiates: Buy
Price Target: $130
Current: $94.28
Upside: +37.89%
Stryker
Sep 18, 2025
Initiates: Neutral
Price Target: $420
Current: $364.02
Upside: +15.38%
Qiagen
Apr 4, 2025
Downgrades: Neutral
Price Target: n/a
Current: $47.01
Upside: -
Lantheus Holdings
Sep 3, 2024
Initiates: Buy
Price Target: $175
Current: $63.30
Upside: +176.46%
Intuitive Surgical
Aug 2, 2024
Upgrades: Buy
Price Target: $380 → $510
Current: $575.34
Upside: -11.36%
GE HealthCare Technologies
Jan 19, 2023
Initiates: Buy
Price Target: n/a
Current: $85.46
Upside: -